Germany's CureVac announced Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech and... Original source: https://www.ndtv.com/world-news/covid-vaccine-from-germanys-curevac-just-48-effective-2476477

Read more of this post